Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Geospatial Analysis to Determine Optimal Distribution of Mobile Stroke Units

Ryan Ramphul, View ORCID ProfileJames C. Grotta
doi: https://doi.org/10.1101/2025.03.04.25323392
Ryan Ramphul
1Department of Epidemiology, Human Genetics and Environmental Science, The University of Texas Health Science Center at Houston, School of Public Health, Houston, TX
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James C. Grotta
1Department of Epidemiology, Human Genetics and Environmental Science, The University of Texas Health Science Center at Houston, School of Public Health, Houston, TX
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James C. Grotta
  • For correspondence: James.c.grotta{at}uth.tmc.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Introduction Mobile Stroke Units (MSUs) provide faster stroke treatment with improved outcomes but are expensive and their urban and rural deployment differs. Geospatial analysis may be useful for planning optimal MSU distribution.

Methods We geo-coded Texas state-designated level-I or II stroke centers that did not overlap catchment areas and mapped 30, 60, 120 and 180-minute drive time buffers around each center, superimposing them on the distribution of stroke patients in the state including estimates of rural, vulnerable and minority populations within each buffer. We assumed that a MSU deployed from these “MSU centers” could rendezvous with emergency medical services (EMS) units halfway between a rural stroke location and the destination stroke center. For each buffer, we compared the number of patients potentially served by the MSU to a “base case” estimate of EMS transport represented by a 30-minute drive time buffer surrounding all non-overlapping level-I, II, III, or IV stroke centers.

Results We identified 11 level-I and 3 level-II potential MSU stroke centers. A 180-minute buffer around each of these (MSU-EMS rendezvous 90 minutes from the stroke center) resulted in 807,310 stroke patients potentially receiving thrombolysis within 3 hours of stroke onset representing 99.8% adult stroke patients in the state; a net increase of 94,076 (13%) patients compared to “base case” and a 277% increase in patients from rural areas. A 120-minute buffer increased total and rural treatments by 9% and 229%. A 60-minute buffer resulted in no net increase in treated patients, though 672,624 more would receive faster care by MSUs.

Conclusion When distributed using geospatial analysis, MSUs can provide faster acute stroke treatment and potentially better outcomes to virtually the entire state of Texas with a particular increase in rural populations that are not currently reached by EMS. Our findings might be useful to health care planners in any state.

BACKGROUND

Management of acute stroke patients in Mobile Stroke Units (MSUs) compared to standard ambulance transport by emergency medical services (EMS) results in more frequent and faster treatment with intravenous thrombolytics (IVT) and better outcome as measured by disability 90 days after the stroke occurs. This benefit has been demonstrated in two large controlled clinical trials1, 2 and confirmed in a “real world” analysis of Get with The Guideline (GWTG) hospitals outside of a strict clinical trial protocol framework3. However, translating these data to widespread implementation of MSUs has several impediments, most importantly MSU cost and lack of reimbursement, and uncertainty about optimal MSU placement4,5. MSU placement in turn must consider population density and stroke incidence, and the 3-4.5-hour IVT treatment time window that will constrain how far MSUs can travel to treat a patient. Geospatial analysis may be an ideal tool to address these issues and help determine where MSUs might be optimally implemented6.

To begin to address these implementation issues, one of the most important variables to consider is the number of patients that can be treated on MSUs. Cost benefit analyses demonstrate that the high fixed costs of operating a MSU are offset to a greater extent by the more patients that they treat7. MSUs in the U.S. treat on average approximately 50 patients per year with IVT8 which computes to first year post-stroke costs per Quality Adjusted Life Year (QALY) gained of $195,000 in patients with no pre-existing disability7. On the other hand, treatment of 150 patients per year, which is the case in the busiest MSUs, results in a cost per QALY of $61,000/yr.

The number of patients treated on MSUs will be influenced by their relative urban vs rural catchment area. MSUs included in the aforementioned MSU efficacy trials, GWTG study, and cost-effectiveness analyses operated primarily in urban communities with catchment areas of 10 miles or less radius from the MSU base station. In this scenario, the MSU, which arrives on scene at roughly the same time as the EMS ambulance, will evaluate and treat the patient on scene within 25 minutes of arrival1. If the patient were instead transported by EMS, the usual EMS transport time to the Emergency Department (ED) where the patient would be treated is also about 25 minutes. Therefore, the time saved by the MSU (30-45 minutes in most studies) is equal to the door to needle time in the ED.

While the majority of stroke patients reside in urban areas, a considerable number, particularly those with the highest risk of stroke, reside in more rural areas. The impact of MSU management in rural areas has been much less studied but would involve the “rendezvous” (RDV) concept. With RDV, the closest EMS ambulance picks up the patient at a distant location and begins transport to the destination ED, while the MSU is dispatched from near the destination ED. The EMS ambulance and MSU RDV somewhere between where the patient is picked up and the destination ED, and the patient treated on the MSU at the RDV point. RDV has been used successfully in some urban MSUs to extend their catchment area into suburban regions9. In a rural area, if the time of transport from the RDV point to the ED were greater than 25 minutes (e.g. the time it would take for the MSU to treat the patient), then the time savings by MSU management would be even greater than in urban areas. Thus, the use of RDV may result in a greater impact on outcome per patient in rural compared to urban areas. This has been demonstrated by the University of Florida MSU which services semi-urban Gainesville and 6 surrounding rural counties. In patients from the rural counties, the average dispatch to needle time for MSU management via RDV was 41.3 minutes compared to 97.8 minutes if patients had to travel by EMS to the stroke center, a net saving of 56.5 minutes10.

Geospatial analysis is increasingly used to analyze distribution issues such as optimal MSU placement that must take into consideration the location of stroke centers, stroke incidence, population density, and time and distances travelled. In this study, we aimed to carry out a Texas statewide geospatial analysis to understand how to provide faster more effective MSU-based treatment to the largest number of Texas stroke patients if MSUs were strategically placed at level I or II state stroke centers, modeling various RDV time/distances to access patients. We hypothesized that MSUs via RDV could substantially increase the number of stroke patients receiving optimized treatment, particularly in rural regions of the state.

METHODS

Texas established stroke designation rules in 2005 to create a state-wide emergency stroke treatment system, ensuring individuals showing acute stroke symptoms are transported to appropriately equipped facilities. These designations, updated in 2022, classify hospitals into four levels based on their capabilities: Level I (Comprehensive Stroke Centers), Level II (Advanced Stroke Centers, which can perform thrombectomy but are not comprehensive), Level III (Primary Stroke Centers), and Level IV (Acute Stroke Ready Centers).

Using ArcGIS Pro Version 3.3.2 {https://www.esri.com/en-us/arcgis/products} we geocoded all level I and II stroke facilities. Data on stroke facilities came from the Texas Department of State Health Services. For strategic placement of MSUs, we included only level I and II centers because it is unlikely that MSU operations would be supported by a level III or IV center and wanted to demonstrate the impact if all non-overlapping Level I and II centers would have MSU programs. Since MSU programs should optimally be coordinated among all the stroke centers in a given community or region, we modeled only 1 MSU if the level I or II stroke centers were located within 30 minutes of each other. Next, we created a series of drive time buffers around each of the “MSU centers” included in our analysis, using ArcGIS Pro. A drive time buffer is a polygon shape of how far one can drive in any direction from each input stroke facility, using the underlying road network, in the specified period. We created a 30-minute drive time buffer as the baseline representing the usual transport time for a standard EMS ambulance, and then one-hour, two-hour, and three-hour drive time buffers to estimate the time and distance travelled if the MSU rendezvoused with an EMS unit inbound from a distant scene. Assuming MSU RDV with EMS halfway between the site of the stroke and the destination level I or II center, the one, two and three-hour buffers would correlate with MSU drive times of 30, 60, or 90 minutes. Although guideline-approved to 4.5 hours, optimal administration of IV thrombolysis should occur within 3 hours of onset. Assuming 1.5 hours for stroke recognition, EMS alerting and arrival, and evaluation and treatment on the MSU upon RDV, we assumed that a MSU drive time of up to 90 minutes from MSU base to RDV (e.g. the 180-minute buffer) might still allow MSU-based treatment within the 3-hour time window.

For comparing MSU stroke coverage to current EMS coverage (i.e. “base case”), we created 30-minute drive time buffers surrounding all non-overlapping level I, II, III, or IV state stroke centers (n= 190). This assumed 1.5 hours for stroke recognition, EMS alerting arrival and evaluation on scene, 30 minutes EMS transport time, and 1 hour door to needle time in the stroke center ED.

Estimating adult populations within different drive times from stroke centers

Next, we utilized the 2020 US Census American Community Survey (ACS) 5-year estimates to estimate the number of adults (18+) within each drive time buffer around each location by summing the number of adults in each census tract whose centroid fell within each respective buffer area.

Estimating stroke prevalence within different drive times from stroke centers

We then multiplied the estimated number of adults 18+ within each of the different drive time buffer rings by 3.7% to estimate the number of adults with stroke within each drive time buffer. We utilized 3.7% as the stroke prevalence rate in Texas based on data from the 2020 Texas Stroke System of Care Report, developed by the Texas Department of State Health Services (DSHS). This report, informed by the Heart Attack and Stroke Data Collection initiative, aggregates de-identified hospital data to evaluate stroke care systems and outcomes. The comprehensive analysis within the report provides a reliable foundation for understanding stroke prevalence and guiding efforts to improve stroke care and prevention across the state.

Estimating rural populations within different drive times from stroke centers

Next, we utilized Rural-Urban Commuting Area (RUCA) codes to estimate rural populations within different drive times from stroke centers. Rural-Urban Commuting Area (RUCA) codes, developed by the U.S. Department of Agriculture, classify geographic areas, in this case census tracts, based on urbanization, population density, and commuting patterns. These codes range from 1 to 10, with lower scores indicating more urban areas and higher scores representing more rural regions. To simplify analyses, researchers frequently group RUCA codes into broader categories to differentiate these settings more effectively and facilitate studies on health disparities, resource allocation, and access to services. As such we grouped RUCA Codes into three categories: urban, rural, and micropolitan (or small-town), in the following manner, based on guidance from the USDA:

  • Urban: RUCA codes 1 through 3, represent areas with high population density and strong commuting ties to urban centers.

  • Micropolitan: RUCA codes 4 through 6, covers smaller towns or regions with moderate commuting ties to urban areas.

  • Rural: RUCA codes 7 through 10, indicate areas with low population density and weak commuting ties to urban centers.

This grouping helps streamline analyses and comparisons while maintaining meaningful distinctions between types of geographic areas. To ensure accuracy, we removed census tracts containing airports, which are often assigned a RUCA score of 10 due to low residential population, but do not represent truly rural areas. To estimate rural populations reachable from different drive time buffers from stroke centers, we calculated the adult populations in rural census tracts (RUCA codes of 7-10) within each buffer. Because of their distance from stroke centers, we assumed that rural patients would be unlikely to receive IVT within 3 hours of stroke onset by current EMS transport.

Estimating socially vulnerable populations within different drive times from stroke centers

To estimate socially vulnerable populations within varying drive times from stroke centers, we utilized the CDC’s 2020 Social Vulnerability Index (SVI). The CDC’s Social Vulnerability Index (SVI) is a tool that uses U.S. Census data to measure the relative social vulnerability of communities based on 19 variables, such as poverty, access to transportation, and housing conditions. These variables are grouped into four themes—socioeconomic status, household composition, minority status and language, and housing/transportation—and combined to produce a percentile ranking for each census tract, with higher scores indicating greater vulnerability. The SVI helps identify areas that may require additional support during public health emergencies or resource allocation efforts.

To estimate especially vulnerable populations, we isolated census tracts with SVI percentile scores of 0.75 or higher, representing the most vulnerable populations. We aggregated the adult populations (18+) in these high-SVI census tracts whose centroids fell within the 30-minute, 1-hour, 2-hour, and 3-hour drive time buffers around stroke centers. This method highlights areas where socially vulnerable populations may face significant barriers to accessing timely stroke care, informing strategies for improved healthcare equity.

Estimating minority populations within different drive times from stroke centers

To estimate minority populations within different drive times from stroke centers, we used census tract-level estimates of the percentage of non-White populations provided in the CDC’s 2020 Social Vulnerability Index (SVI) data package. We aggregated the adult populations (18+) in census tracts based on the proportion of non-White residents and whose centroids fell within the 30-minute, 1-hour, 2-hour, and 3-hour drive time buffers. This approach allows for a detailed assessment of disparities in stroke care accessibility among minority populations, offering crucial insights into areas that may require targeted interventions to reduce health inequities.

RESULTS

Calculating from the American Community Survey 5-year 2021 estimates, there are 809,067 adult stroke patients in Texas of whom an estimated 39,235 reside in rural areas and therefore currently unlikely to receive acute stroke treatment with IVT within 3 hours of stroke onset.

Additionally, data from the CDC PLACES project indicates considerable stroke geographic heterogeneity, with high prevalence in rural regions particularly in East Texas and along the Mexican border (Figure 1). Using the criteria described in the Methods, we identified 11 potential MSU locations with level I facilities, and 3 with level II (Amarillo, Odessa, and Burlesson) (Figure 2). Superimposing figure 2 on figure 1 provides a visual representation of the proportion of stroke patients that might be served by MSUs using the RDV approach. The data are presented in Table 1.

Figure 1.
  • Download figure
  • Open in new tab
Figure 1. Stroke Prevalence by Census Tract CDC PLACES 2022.
Figure 2.
  • Download figure
  • Open in new tab
Figure 2. Drive Time Buffers Around Potential MSU Equipped Level I or II Stroke Facilities.
View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1. Modeling of Additional Stroke Patients That Could Be Served.

A one-hour drive time radius around each of the 14 MSU centers in our sample (MSU-EMS RDV 30 minutes from the stroke center) resulted in no net increase in the estimated number of stroke patients that could be treated on MSUs compared to the number treated following transport by EMS to the 190 level I-IV stroke centers around the state within a 30-minute drive time. However, the 672,624 patients treated on MSUs would be treated faster and consequently have a greater chance of good outcome compared to if they were transported by EMS1,2

By increasing the MSU service area to a two-hour drive time radius around each of the 14 MSU centers in our sample (MSU-EMS RDV 1 hour from the stroke center), an estimated 777,904 patients could receive faster more optimized treatment on a MSU, including a net increase of 64,670 or 9% more stroke patients treated with IVT than with existing EMS coverage. About 36% of this increase (23,714 patients) would be from rural areas, which is a 229% increase compared to existing EMS coverage. Roughly equal numbers though proportionately smaller increases would occur in socially vulnerable and minority patients treated.

Finally, by increasing the MSU service area to a three-hour drive time radius around each of the 14 MSU stroke centers in our sample (MSU-EMS RDV 90 minutes from the stroke center), an estimated 807,310 patients representing 99.8% of all adult patients suffering from stroke in the state could receive faster more optimized treatment on a MSU, including a net increase of 94,076 or 13% more stroke patients treated with IVT than with existing EMS coverage. Further proportionate increases were seen in rural, socially vulnerable and minority populations.

DISCUSSION

Our data demonstrate that strategic location of MSU programs linked to 14 level I or level II stroke centers in Texas could substantially increase the number of stroke patients receiving faster more optimized MSU-based IVT treatment within 3 hours of stroke onset, reaching 99.8% of stroke patients in the state. This would have a particularly striking impact on increasing coverage of rural areas where stroke incidence is highest and where patients must travel great distances to reach a major stroke center. Currently rural patients with stroke are less likely to receive IVT or endovascular therapy and have higher in-hospital mortality than their urban counterparts11. One problem with new technological advances is that once implemented they are often not as available to remote, socially vulnerable and minority populations. Our data demonstrate that this would not be the case with geospatially guided MSU implementation.

Our findings, though based on modeling of Texas stroke centers and population density, might be useful to health care planners in any state. MSUs are a beneficial cost-effective innovation but are expensive and labor intensive to implement and operate. Communities must therefore decide if they can support a MSU, and health care planners must decide where they should be optimally located to deliver faster and more frequent treatment to patients who are located a substantial distance from the destination stroke center. In Texas, legislation has been introduced to provide funding for new MSU programs. Such support is essential until appropriate reimbursement for MSU services is provided by health care payers. Our geospatial analysis could be useful for the Texas legislature and for any state or health care planner to understand where MSU support might be best targeted.

MSUs must be licensed and staffed with sophisticated equipment such as CT scanners, and nursing and technological personnel familiar with stroke diagnosis and treatment. Therefore, all MSUs in current operation in the U.S. are operated by hospital systems in collaboration with local EMS. Level I stroke centers provide the full range of stroke treatments and are the current “home” for all MSUs in the U.S. However, level II centers can provide all stroke treatments including thrombectomy so might be able to support a MSU program in an area where a level I center is not available. These considerations guided the selection of the stroke centers where MSU programs would be located in the state for our analysis.

In urban areas, level I stroke centers tend to cluster and overlap catchment areas. It would not be efficient for each level I center to operate a MSU. Instead, in all communities with MSUs in the U.S., the MSU is operated by one level I center, but collaborates with others. Since the average EMS transport time to level I centers in urban areas is approximately 20-30 minutes, we considered all level I and II stroke centers as a single center if they were within 30 minutes of one another. In population-dense urban areas, there would be a need for more than one MSU. If each of the 4 highly urban areas in the state had at least two MSUs so that one would be available for RDV from an ex-urban area while the others were available for the city, we calculate that a total of 18-24 MSUs could provide faster optimized MSU-based stroke treatment to the entire population of the state.

As with any modeling exercise, we have made several assumptions, and the main limitation of our study is that it is based on these assumptions. While MSUs and EMS ambulances in urban areas usually have a roughly 10-mile radius catchment area, corresponding to an approximate 20-30-minute drive time, MSUs can cover a much larger area by using the RDV approach. With RDV, the MSU meets the EMS squad travelling with the patient from the distant site of the stroke, usually about halfway between the MSU base station and the site of the distant stroke, and treats the patient at the RDV site. For our study, we used the 30-minute drive time as the current “base” condition for both EMS and MSUs, and modeled MSU catchment areas based on drive times of 60, 120, and 180 minutes from the receiving stroke center, corresponding to MSU drive times of 30, 60, and 90 minutes from MSU base to RDV. Although guideline-approved to 4.5 hours from stroke onset, the benefit of IVT quickly decays with treatment beyond 1 hour12 and is FDA approved within 3 hours. Therefore, we used the 3-hour time window as the goal for IVT delivery for this study. optimal administration of IV thrombolysis must occur within 3 hours of onset. Assuming 1 hour for stroke recognition and EMS arrival and evaluation on scene, and 30 minutes for treatment on the MSU upon RDV, an MSU drive time of over 90 minutes from MSU base to RDV (over 180 minutes total transport time) would probably put the patient outside the 3-hour time window. In more remote regions, certainly MSUs could travel longer distances but would not likely lead to treatment within 3 hours. Interestingly, a recent analysis showed that stroke treatment of remote patients transported by helicopter ambulance is slower than ground transport13 so it is unlikely that air transport would be faster than EMS-MSU RDV except for exceptionally long distances. Our results correspond well with findings from Gainesville which is the only existing MSU program with published data on rural populations10.

We also had to make assumptions about how to compare projected MSU coverage to existing coverage by EMS without MSUs. All Texas state level I-IV stroke centers can treat stroke patients with IVT. Therefore, for our base case scenario, we used a 30-minute drive-time catchment area surrounding all 190 non-overlapping (e.g. not within 30-minutes of a neighboring stroke center) level I-IV stroke centers in the state. We used the 30-minute catchment area since a 20-30-minute drive time is average for most EMS units transporting stroke patients, and a substantially longer drive-time would probably make IVT treatment unlikely within 3 hours of onset.

In conclusion, using geospatial modeling to optimize their strategic location, MSUs can provide faster more effective stroke treatment to the vast majority of stroke patients in Texas, including rural, socially vulnerable and minority populations, including rural, socially vulnerable and minority populations. MSU rendezvous with EMS travelling from 2 hours away will increase the number of rural patients receiving treatment by 229%, and from 3 hours away could provide faster optimized MSU-based treatment for 99.8% of all stroke patients in the state.

Data Availability

The data used in this study were obtained from publicly available sources, including the Texas Department of State Health Services, the 2020 U.S. Census American Community Survey (ACS) 5-year estimates, the CDC PLACES project, and the CDC Social Vulnerability Index (SVI). Geospatial analyses were conducted using ArcGIS Pro. Any additional data supporting the findings of this study are available from the corresponding author upon reasonable request.

Sources of Funding

Patient Centered Outcomes Research Institute: PCORI R-1511-33024.

Disclosures

Dr Grotta receives consulting fees from Frazer Ltd, a manufacturer of Mobile Stroke Units

References

  1. 1.↵
    Grotta J C, Yamal J-M, Parker SA, et al. Prospective, Multicenter, Controlled Trial of Mobile Stroke Units. New Engl J Med 385:971–81, 2021.
    OpenUrlCrossRefPubMed
  2. 2.↵
    Ebinger M, Siegerink B, Kunz A, et al. Berlin_PRehospital Or Usual Delivery in stroke care (B_PROUD) study group. Association Between Dispatch of Mobile Stroke Units and Functional Outcomes Among Patients With Acute Ischemic Stroke in Berlin. JAMA. 2021;325:454–466
    OpenUrlCrossRefPubMed
  3. 3.↵
    Mac Grory B, Sun JL, Alhanti B, et al. Mobile Stroke Unit Management in Patients With Acute Ischemic Stroke Eligible for Intravenous Thrombolysis. JAMA Neurol. 2024;81:1250–1262
    OpenUrlPubMed
  4. 4.↵
    Lees KR. Does My District Need a Mobile Stroke Unit? N Engl J Med. 2021;385:1043–1044
    OpenUrlPubMed
  5. 5.↵
    Navi BB, Khatri P. Mobile Stroke Units-Time for Legislation and Remuneration. JAMA Neurol. 2024;81:1247–1249
    OpenUrlPubMed
  6. 6.↵
    Nykiforuk, C. I., & Flaman, L. M. Geographic Information System (GIS) use in health-related research: A review. Health & Place. 2011;17: 361–370
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    Rajan SS, Yamal JM, Wang M, et al. A Prospective Multicenter Analysis of Mobile Stroke Unit Cost-Effectiveness. Ann Neurol. 2025;97:209–221
    OpenUrlPubMed
  8. 8.↵
    Ellens NR, Schartz D, Rahmani R, et al. Mobile Stroke Unit Operational Metrics: Institutional Experience, Systematic Review and Meta-Analysis. Front Neurol. 2022;13:868051
    OpenUrlPubMed
  9. 9.↵
    Parker SA, Kus T, Bowry R, et al. Enhanced dispatch and rendezvous doubles the catchment area and number of patients treated on a mobile stroke unit. J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104894. doi: 10.1016/j.jstrokecerebrovasdis.2020.104894
    OpenUrlCrossRefPubMed
  10. 10.↵
    Davis NW, Fayed M, Hardee E, et al. Transforming Early Stroke Care Through Mobile Stroke Treatment Unit Rendezvous With Rural Emergency Medical Services. Stroke. 2025 Jan 30. doi: 10.1161/STROKEAHA.124.048633.
    OpenUrlCrossRef
  11. 11.↵
    Hammond G, Luke AA, Elson L, Towfighi A, Joynt Maddox KE. Urban-Rural Inequities in Acute Stroke Care and In-Hospital Mortality. Stroke. 2020;51:2131–2138
    OpenUrlCrossRefPubMed
  12. 12.↵
    Mackey J, Yamal JM, Parker SA, et al. BEST-MSU Study Group. Golden Hour Treatment With tPA (Tissue-Type Plasminogen Activator) in the BEST-MSU Study. Stroke. 2023;54:415–425
    OpenUrlPubMed
  13. 13.↵
    Cash RE, Boggs KM, Richards CT, Camargo CA Jr., Zachrison KS. Emergency Medical Service Time Intervals for Patients With Suspected Stroke in the United States. Stroke. 2022;53:e75–e78.
    OpenUrlPubMed
Back to top
PreviousNext
Posted March 05, 2025.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Geospatial Analysis to Determine Optimal Distribution of Mobile Stroke Units
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Geospatial Analysis to Determine Optimal Distribution of Mobile Stroke Units
Ryan Ramphul, James C. Grotta
medRxiv 2025.03.04.25323392; doi: https://doi.org/10.1101/2025.03.04.25323392
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Geospatial Analysis to Determine Optimal Distribution of Mobile Stroke Units
Ryan Ramphul, James C. Grotta
medRxiv 2025.03.04.25323392; doi: https://doi.org/10.1101/2025.03.04.25323392

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Neurology
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3281)
  • Dentistry and Oral Medicine (362)
  • Dermatology (274)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1164)
  • Epidemiology (13336)
  • Forensic Medicine (19)
  • Gastroenterology (896)
  • Genetic and Genomic Medicine (5127)
  • Geriatric Medicine (479)
  • Health Economics (780)
  • Health Informatics (3250)
  • Health Policy (1137)
  • Health Systems and Quality Improvement (1189)
  • Hematology (427)
  • HIV/AIDS (1012)
  • Infectious Diseases (except HIV/AIDS) (14611)
  • Intensive Care and Critical Care Medicine (908)
  • Medical Education (475)
  • Medical Ethics (126)
  • Nephrology (521)
  • Neurology (4898)
  • Nursing (261)
  • Nutrition (725)
  • Obstetrics and Gynecology (879)
  • Occupational and Environmental Health (795)
  • Oncology (2515)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (346)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (537)
  • Pediatrics (1297)
  • Pharmacology and Therapeutics (548)
  • Primary Care Research (554)
  • Psychiatry and Clinical Psychology (4189)
  • Public and Global Health (7482)
  • Radiology and Imaging (1700)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (478)
  • Sexual and Reproductive Health (493)
  • Sports Medicine (424)
  • Surgery (545)
  • Toxicology (71)
  • Transplantation (235)
  • Urology (203)